Symptomatic hypophosphataemic osteomalacia secondary to the treatment with iron carboxymaltose detected in bone scintigraphy;Osteomalacia hipofosfatémica sintomática secundaria a tratamiento con hierro carboximaltosa objetivada con gammagrafía ósea

Revista Espanola de Medicina Nuclear e Imagen Molecular

Volumn 35, Issue 6, 2016, Pages 391-393

  Sangros Sahun M J ^a   Goni Girones E ^b   Camarero Salazar, A ^b   Estebanez Estebanez C ^b   Lozano Martinez M E ^b  

^a HOSPITAL UNIVERSITARIO MIGUEL SERVET   (Spain)

^b Universidad Pública de Navarra   (Spain)

Author keywords

Bone scintigraphy; Ferric carboxymaltose; Hypophosphataemia; Osteomalacia

Indexed keywords

FERRIC CARBOXYMALTOSE; IRON; FERRIC ION; MALTOSE;

ANEMIA; ARTICLE; BONE SCINTISCANNING; DISEASE ASSOCIATION; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; FOLLOW UP; HUMAN; HYPOPHOSPHATEMIC RICKETS; MEDICAL HISTORY; MENORRHAGIA; PATIENT ASSESSMENT; ADULT; ANALOGS AND DERIVATIVES; BONE; CASE REPORT; CHEMICALLY INDUCED; DIAGNOSTIC IMAGING; FEMALE; HYPOPHOSPHATEMIA; OSTEOMALACIA; SCINTISCANNING;

ADULT; BONE AND BONES; FEMALE; FERRIC COMPOUNDS; HUMANS; HYPOPHOSPHATEMIA; MALTOSE; OSTEOMALACIA; RADIONUCLIDE IMAGING;

EID: 84970038668     PISSN: 2253654X     EISSN: 22538070     Source Type: Journal    
DOI: 10.1016/j.remn.2016.04.006     Document Type: Article

References (10)

1. 1 Van Wyck, D.B., Mangione, A., Morrison, J., Hadley, P.E., Jehle, J.A., Goodnough, L.T., Large-dose intravenous ferric carboxymaltose injection for iron deficiency anemia in heavy uterine bleeding: A randomized, controlled trial. Transfusion. 49 (2009), 2719–2728.
2. 2 Sánchez González, R., Ternavasio-de la Vega, H.G., Moralejo Alonso, L., Inés Revuelta, S., Fuertes Martín, A., Intravenous ferric carboxymaltose-associated hypophosphatemia in patients with iron deficiency anemia. A common side effect. Med Clin (Barc). 145 (2015), 108–111.
3. 3 Blazevic, A., Hunze, J., Boots, J.M., Severe hypophosphataemia after intravenous iron administration. Neth J Med. 72 (2014), 49–53.
4. 4 Roselló, L., Gort, A., Planella, R., Cabau, J., Hypophosphatemia and multiple fractures in patient with human immunodeficiency virus infection treated with tenofovir. Med Clin (Barc)., 129, 2007, 197.
5. 5 Wolf, M., Koch, T.A., Bregman, D.B., Effects of iron deficiency anemia and its treatment on fibroblast growth factor 23 and phosphate homeostasis in women. J Bone Miner Res. 28 (2013), 1793–1803.
6. 6 Schouten, B.J., Doogue, M.P., Soule, S.G., Hunt, P.J., Iron polymaltose-induced FGF23 elevation complicated by hypophosphataemic osteomalacia. Ann Clin Biochem. 46 (2009), 167–169.
7. 7 Ros, I., Alvarez, L., Guañabens, N., Peris, P., Monegal, A., Vázquez, I., et al. Hypophosphatemic osteomalacia: A report of five cases and evaluation of bone markers. J Bone Miner Metab. 23 (2005), 266–269.
8. 8 Gómez Martínez, M.V., Gallardo, F.G., Pirogova, T., García-Samaniego, J., Bone scintigraphy and secondary osteomalacia due to nephrotoxicity in a chronic hepatitis B patient treated with tenofovir. Rev Esp Med Nucl Imagen Mol. 33 (2014), 103–105.
9. 9 Torres Isidro, M.V., García Benayas, T., Gómez Martínez, M.V., González Gallardo, F., Gambí Pisonero, N., Castilla Miguel, S., et al. Utilidad de la gammagrafía ósea en el diagnóstico de osteomalacia secundaria en un paciente en tratamiento con tenofovir. Role of bone gammagraphy in the diagnosis of osteomalacy secondary to tenofovir treatment. Rev Esp Med Nucl. 25 (2006), 103–106.
10. 10 Kim, D.H., Sung, D.H., Min, Y.K., Hypophosphatemic osteomalacia induced by low-dose adefovir therapy: Focus on manifestations in the skeletal system and literature review. J Bone Miner Metab. 31 (2013), 240–246.